Report Detail
Global (United States, European Union and China) Cancer Pain Therapeutics Market Research Report 2019-2025
- RnM3579070 |
- 08 July, 2019 |
- Global |
- 110 Pages |
- QYResearch |
- Pharma & Healthcare
Pain in cancer may come from compressing or infiltrating nearby body parts, from treatments and diagnostic procedures or from skin, nerve, and the other changes caused by a hormone imbalance or immune response.
Factors such as the unmet medical needs of patients drive the market growth during the forecast period. Currently, the drugs that are available for reducing pains associated with cancer have a prolonged duration of action and are characterized by undesirable effects like sedation and respiratory depression. Consequently, this presents an opportunity for the vendors to bring in therapies with fewer side effects and a better efficacy parameter.
In 2019, the market size of Cancer Pain Therapeutics is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Cancer Pain Therapeutics.
This report studies the global market size of Cancer Pain Therapeutics, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Cancer Pain Therapeutics sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
BioDelivery Science
ProStrakan Group
Teva pharmaceuticals
Eli-Lilly
Grunenthal Group
GW Pharmaceuticals
Johnson＆Johnson
Meda Pharmaceuticals
Orexo
Sanofi
WEX Pharmaceuticals
Market Segment by Product Type
Opioids
Non-Steroidal Anti-Inflammatory Drugs
Others
Market Segment by Application
Paracetamol Treatment-Related Immunotherapy
Radiotherapy
Chemotherapy
Hormone Therapy
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Cancer Pain Therapeutics status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Cancer Pain Therapeutics manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Cancer Pain Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Cancer Pain Therapeutics Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Opioids
- 1.3.3 Non-Steroidal Anti-Inflammatory Drugs
- 1.3.4 Others
- 1.4 Market Segment by Application
- 1.4.1 Global Cancer Pain Therapeutics Market Share by Application (2019-2025)
- 1.4.2 Paracetamol Treatment-Related Immunotherapy
- 1.4.3 Radiotherapy
- 1.4.4 Chemotherapy
- 1.4.5 Hormone Therapy
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Cancer Pain Therapeutics Market Size
- 2.1.1 Global Cancer Pain Therapeutics Revenue 2014-2025
- 2.1.2 Global Cancer Pain Therapeutics Sales 2014-2025
- 2.2 Cancer Pain Therapeutics Growth Rate by Regions
- 2.2.1 Global Cancer Pain Therapeutics Sales by Regions 2014-2019
- 2.2.2 Global Cancer Pain Therapeutics Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Cancer Pain Therapeutics Sales by Manufacturers
- 3.1.1 Cancer Pain Therapeutics Sales by Manufacturers 2014-2019
- 3.1.2 Cancer Pain Therapeutics Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Cancer Pain Therapeutics Revenue by Manufacturers (2014-2019)
- 3.2.2 Cancer Pain Therapeutics Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Cancer Pain Therapeutics Market Concentration Ratio (CR5 and HHI)
- 3.3 Cancer Pain Therapeutics Price by Manufacturers
- 3.4 Key Manufacturers Cancer Pain Therapeutics Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Cancer Pain Therapeutics Market
- 3.6 Key Manufacturers Cancer Pain Therapeutics Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Opioids Sales and Revenue (2014-2019)
- 4.1.2 Non-Steroidal Anti-Inflammatory Drugs Sales and Revenue (2014-2019)
- 4.1.3 Others Sales and Revenue (2014-2019)
- 4.2 Global Cancer Pain Therapeutics Sales Market Share by Type
- 4.3 Global Cancer Pain Therapeutics Revenue Market Share by Type
- 4.4 Cancer Pain Therapeutics Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Cancer Pain Therapeutics Sales by Application
6 United States
- 6.1 United States Cancer Pain Therapeutics Breakdown Data by Company
- 6.2 United States Cancer Pain Therapeutics Breakdown Data by Type
- 6.3 United States Cancer Pain Therapeutics Breakdown Data by Application
7 European Union
- 7.1 European Union Cancer Pain Therapeutics Breakdown Data by Company
- 7.2 European Union Cancer Pain Therapeutics Breakdown Data by Type
- 7.3 European Union Cancer Pain Therapeutics Breakdown Data by Application
8 China
- 8.1 China Cancer Pain Therapeutics Breakdown Data by Company
- 8.2 China Cancer Pain Therapeutics Breakdown Data by Type
- 8.3 China Cancer Pain Therapeutics Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Cancer Pain Therapeutics Breakdown Data by Company
- 9.2 Rest of World Cancer Pain Therapeutics Breakdown Data by Type
- 9.3 Rest of World Cancer Pain Therapeutics Breakdown Data by Application
- 9.4 Rest of World Cancer Pain Therapeutics Breakdown Data by Countries
- 9.4.1 Rest of World Cancer Pain Therapeutics Sales by Countries
- 9.4.2 Rest of World Cancer Pain Therapeutics Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 BioDelivery Science
- 10.1.1 BioDelivery Science Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Cancer Pain Therapeutics
- 10.1.4 Cancer Pain Therapeutics Product Introduction
- 10.1.5 BioDelivery Science Recent Development
- 10.2 ProStrakan Group
- 10.2.1 ProStrakan Group Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Cancer Pain Therapeutics
- 10.2.4 Cancer Pain Therapeutics Product Introduction
- 10.2.5 ProStrakan Group Recent Development
- 10.3 Teva pharmaceuticals
- 10.3.1 Teva pharmaceuticals Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Cancer Pain Therapeutics
- 10.3.4 Cancer Pain Therapeutics Product Introduction
- 10.3.5 Teva pharmaceuticals Recent Development
- 10.4 Eli-Lilly
- 10.4.1 Eli-Lilly Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Cancer Pain Therapeutics
- 10.4.4 Cancer Pain Therapeutics Product Introduction
- 10.4.5 Eli-Lilly Recent Development
- 10.5 Grunenthal Group
- 10.5.1 Grunenthal Group Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Cancer Pain Therapeutics
- 10.5.4 Cancer Pain Therapeutics Product Introduction
- 10.5.5 Grunenthal Group Recent Development
- 10.6 GW Pharmaceuticals
- 10.6.1 GW Pharmaceuticals Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Cancer Pain Therapeutics
- 10.6.4 Cancer Pain Therapeutics Product Introduction
- 10.6.5 GW Pharmaceuticals Recent Development
- 10.7 Johnson＆Johnson
- 10.7.1 Johnson＆Johnson Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Cancer Pain Therapeutics
- 10.7.4 Cancer Pain Therapeutics Product Introduction
- 10.7.5 Johnson＆Johnson Recent Development
- 10.8 Meda Pharmaceuticals
- 10.8.1 Meda Pharmaceuticals Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of Cancer Pain Therapeutics
- 10.8.4 Cancer Pain Therapeutics Product Introduction
- 10.8.5 Meda Pharmaceuticals Recent Development
- 10.9 Orexo
- 10.9.1 Orexo Company Details
- 10.9.2 Company Description and Business Overview
- 10.9.3 Sales, Revenue and Market Share of Cancer Pain Therapeutics
- 10.9.4 Cancer Pain Therapeutics Product Introduction
- 10.9.5 Orexo Recent Development
- 10.10 Sanofi
- 10.10.1 Sanofi Company Details
- 10.10.2 Company Description and Business Overview
- 10.10.3 Sales, Revenue and Market Share of Cancer Pain Therapeutics
- 10.10.4 Cancer Pain Therapeutics Product Introduction
- 10.10.5 Sanofi Recent Development
- 10.11 WEX Pharmaceuticals
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Cancer Pain Therapeutics Sales Channels
- 11.2.2 Cancer Pain Therapeutics Distributors
- 11.3 Cancer Pain Therapeutics Customers
12 Market Forecast
- 12.1 Global Cancer Pain Therapeutics Sales and Revenue Forecast 2019-2025
- 12.2 Global Cancer Pain Therapeutics Sales Forecast by Type
- 12.3 Global Cancer Pain Therapeutics Sales Forecast by Application
- 12.4 Cancer Pain Therapeutics Forecast by Regions
- 12.4.1 Global Cancer Pain Therapeutics Sales Forecast by Regions 2019-2025
- 12.4.2 Global Cancer Pain Therapeutics Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Cancer Pain Therapeutics. Industry analysis & Market Report on Cancer Pain Therapeutics is a syndicated market report, published as Global (United States, European Union and China) Cancer Pain Therapeutics Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Cancer Pain Therapeutics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
